In this pooled analysis of four U.S. clinical trials conducted between 2007 and 2013, researchers evaluated the long-term glycemic control and safety of bariatric surgery (Roux-en-Y gastric bypass, sleeve gastrectomy, adjustable gastric banding) compared with lifestyle measures coupled with drug therapy for type 2 diabetes. A total of 262 patients were followed for 7 to 12 years. At the end of this follow-up, patients who had undergone bariatric surgery had better glycemic control, less use of antidiabetic drugs and a higher rate of diabetes control, compared with patients who had benefited from hygienic-dietary measures coupled with medication.
Last press reviews
COVID-19 and coagulation parameters: a link to mortality?
The COVID-19 pandemic, caused by SARS-CoV-2, has led to millions of deaths...
Resistance training and Multiple Sclerosis: a solution to improve function and quality of life?
Multiple sclerosis (MS) is a chronic autoimmune disease of the central ner...
Endometriosis: the Impact of hormones, sexual practice, and surgical treatments
Endometriosis is a chronic inflammatory disease modulated by estrogen leve...